Yan Lily D, Thomas Dylan, Schwartz Michael, Reich Jason, Steenkamp Devin
Departments of Internal Medicine.
Endocrinology, and.
J Endocr Soc. 2017 Feb 15;1(3):231-236. doi: 10.1210/js.2016-1065. eCollection 2017 Mar 1.
Graves thyrotoxicosis rarely presents with painless jaundice resulting from hyperthyroidism-associated hepatotoxicity, without preexisting liver disease. Management in patients with this presentation is challenging, given that the thionamides, methimazole and propylthiouracil, have both been associated with drug-induced liver injury. Radioactive iodine ablation and thyroidectomy are well-established alternatives, but each have their associated risks and contraindications. We present an unusual case of severe hyperthyroidism-associated hepatotoxicity, in which adjuvant therapies, including glucocorticoids, saturated solution of potassium iodide, and cholestyramine, were used as a bridge to definitive therapy with thyroidectomy.
格雷夫斯甲状腺毒症很少出现由甲状腺功能亢进相关肝毒性导致的无痛性黄疸,且不存在既往肝脏疾病。鉴于硫代酰胺类药物甲巯咪唑和丙硫氧嘧啶均与药物性肝损伤有关,因此对有此表现的患者进行管理具有挑战性。放射性碘消融和甲状腺切除术是公认的替代治疗方法,但每种方法都有其相关风险和禁忌证。我们报告一例罕见的严重甲状腺功能亢进相关肝毒性病例,其中使用了包括糖皮质激素、碘化钾饱和溶液和考来烯胺在内的辅助治疗作为甲状腺切除确定性治疗的过渡。